Monte Rosa Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

몬테 로사 테라퓨틱스NASDAQ:GLUE · Nasdaq · Healthcare · sector #16

$9.87-3.89%

2026-10-06 close · prelim

Monte Rosa Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $76M. 2024 operating profit was −$81M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy